Orient Biotech and its subsidiaries have obtained multiple medical device registration certificates

According to the Zhitong Finance APP, Orient Biotech announced that the company and its subsidiary Shanghai Wanzi Health Biotechnology Co., Ltd. recently obtained the following China Medical Device Registration Certificates (in vitro diagnostic reagents), with the product names as follows: Hepatitis B Virus Surface Antigen (HBsAg) Test Reagent (Colloidal Gold Method), Carbohydrate Antigen 50 Test Kit (Flow Fluorescence Luminance Method), Carbohydrate Antigen 242 Test Kit (Flow Fluorescence Luminance Method)

According to the Zhitong Finance APP, Orient Biotech (688298.SH) announced that the company and its subsidiary Shanghai Wanzi Jian Biotechnology Co., Ltd. recently obtained the following Chinese medical device registration certificates (in vitro diagnostic reagents), with the product names as follows: Hepatitis B virus surface antigen (HBsAg) detection reagent (colloidal gold method), carbohydrate antigen 50 detection reagent kit (flow fluorescence luminescence method), carbohydrate antigen 242 detection reagent kit (flow fluorescence luminescence method)